1Ascherio A, Rimm EB, Giovannucci EL, et al. (1996) Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ 313, 84–90.
2Pietinen P, Ascherio A, Korhonen P, et al. (1997) Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol 145, 876–887.
3Oh K, Hu FB, Manson JE, et al. (2005) Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the Nurses' Health Study. Am J Epidemiol 161, 672–679.
4Oomen CM, Ocke MC, Feskens EJ, et al. (2001) Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 357, 746–751.
5Kuhnlein HV, Receveur O, Soueida R, et al. (2004) Arctic indigenous peoples experience the nutrition transition with changing dietary patterns and obesity. J Nutr 134, 1447–1453.
6Pars T, Osler M & Bjerregaard P (2001) Contemporary use of traditional food among Greenlandic Inuit. Arctic 54, 22–31.
7Blanchet C, Dewailly E, Ayotte P, et al. (2000) Contribution of selected traditional and market foods to the diet of Nunavik Inuit women. Can J Diet Pract Res 61, 50–59.
8Nobmann ED, Ponce R, Mattil C, et al. (2005) Dietary intakes vary with age among Eskimo adults of Northwest Alaska in the GOCADAN study, 2000–2003. J Nutr 135, 856–862.
9Searles E (2002) Food and the making of Inuit identity. Food Foodways 10, 55–78.
10Counil E, Dewailly E, Bjerregaard P, et al. (2008) Trans-polar-fat: all Inuit are not equal. Br J Nutr 100, 703–706.
11Sun Q, Ma J, Campos H, et al. (2007) Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr 86, 74–81.
12Sun Q, Ma J, Campos H, et al. (2007) A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 115, 1858–1865.
13Kabagambe EK, Tsai MY, Hopkins PN, et al. (2008) Erythrocyte fatty acid composition and the metabolic syndrome: a National Heart, Lung, and Blood Institute GOLDN study. Clin Chem 54, 154–162.
14Dewailly E, Blanchet C, Lemieux S, et al. (2001) n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am J Clin Nutr 74, 464–473.
15Dewailly E, Blanchet C, Gingras S, et al. (2002) Cardiovascular disease risk factors and n-3 fatty acid status in the adult population of James Bay Cree. Am J Clin Nutr 76, 85–92.
16Mensink RP, Zock PL, Kester ADM, et al. (2003) Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 77, 1146–1155.
17Mozaffarian D, Katan MB, Ascherio A, et al. (2006) Medical progress – trans fatty acids and cardiovascular disease. N Engl J Med 354, 1601–1613.
18Institut National de Santé Publique du Québec & Nunavik Regional Board of Health and Social Services (2007) Nunavik Inuit Health Survey 2004/Qanuippitaa? How are we? Methodological Report. Québec: Institut National de Santé Publique du Québec.
19Shaikh NA & Downar E (1981) Time course of changes in porcine myocardial phospholipid levels during ischemia. A reassessment of the lysolipid hypothesis. Circ Res 49, 316–325.
20Lepage G & Roy CC (1986) Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27, 114–120.
21Albers JJ, Warnick GR, Wiebe D, et al. (1978) Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. Clin Chem 24, 853–856.
22Tremblay AJ, Morrissette H, Gagne JM, et al. (2004) Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with β-quantification in a large population. Clin Biochem 37, 785–790.
23Lamarche B, Tchernof A, Mauriege P, et al. (1998) Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 279, 1955–1961.
24St-Pierre AC, Ruel IL, Cantin B, et al. (2001) Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation 104, 2295–2299.
25Matthews DR, Hosker JP, Rudenski AS, et al. (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419.
26Pickering TG, Hall JE, Appel LJ, et al. (2005) Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens (Greenwich) 7, 102–109.
27Lohman T, Roche A & Martorell R (1988) . In Anthropometric Standardization Reference Manual, pp. 53–80 [Lohman R, editor]. Champaign, IL: Human Kinetics.
28Williams CM (2004) Lipid metabolism in women. Proc Nutr Soc 63, 153–160.
29Genest J (2008) The Yin and Yang of high-density lipoprotein cholesterol. J Am Coll Cardiol 51, 643–644.
30Stampfer MJ, Sacks FM, Salvini S, et al. (1991) A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 325, 373–381.
31Mensink RP & Katan MB (1990) Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med 323, 439–445.
32Zock PL & Katan MB (1992) Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in humans. J Lipid Res 33, 399–410.
33Lichtenstein AH, Ausman LM, Jalbert SM, et al. (1999) Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med 340, 1933–1940.
34Matthan NR, Welty FK, Barrett PH, et al. (2004) Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women. Arterioscler Thromb Vasc Biol 24, 1092–1097.
35Mauger JF, Lichtenstein AH, Ausman LM, et al. (2003) Effect of different forms of dietary hydrogenated fats on LDL particle size. Am J Clin Nutr 78, 370–375.
36Mitmesser SH & Carr TP (2005) Trans fatty acids alter the lipid composition and size of apoB-100-containing lipoproteins secreted by HepG2 cells. J Nutr Biochem 16, 178–183.
37Berneis KK & Krauss RM (2002) Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 43, 1363–1379.
38Sacks FM & Campos H (2003) Clinical review 163. Cardiovascular endocrinology: low-density lipoprotein size and cardiovascular disease: a reappraisal. J Clin Endocrinol Metab 88, 4525–4532.
39Lamarche B, St-Pierre AC, Ruel IL, et al. (2001) A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men. Can J Cardiol 17, 859–865.
40El HK, van der Steeg WA, Stroes ES, et al. (2007) Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 49, 547–553.
41Dyerberg J, Eskesen DC, Andersen PW, et al. (2004) Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study. Eur J Clin Nutr 58, 1062–1070.
42Roeters van Lennep JE, Westerveld HT, Erkelens DW, et al. (2002) Risk factors for coronary heart disease: implications of gender. Cardiovasc Res 53, 538–549.
43Judd JT, Clevidence BA, Muesing RA, et al. (1994) Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women. Am J Clin Nutr 59, 861–868.
44Chardigny JM, Destaillats F, Malpuech-Brugere C, et al. (2008) Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the Trans Fatty Acids Collaboration (TRANSFACT) study. Am J Clin Nutr 87, 558–566.
45Knopp RH, Paramsothy P, Retzlaff BM, et al. (2006) Sex differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease. Curr Cardiol Rep 8, 452–459.
46Gillmer MD (1992) Mechanism of action/effects of androgens on lipid metabolism. Int J Fertil 37, Suppl. 2, 83–92.
47Lapointe A, Balk EM & Lichtenstein AH (2006) Gender differences in plasma lipid response to dietary fat. Nutr Rev 64, 234–249.
48Cooper GR, Myers GL, Smith SJ, et al. (1992) Blood lipid measurements. Variations and practical utility. JAMA 267, 1652–1660.
49Pereira MA, Kartashov AI, Ebbeling CB, et al. (2005) Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis. Lancet 365, 36–42.
50Hu FB, Li TY, Colditz GA, et al. (2003) Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA 289, 1785–1791.
51American Diabetes Association (2008) Standards of medical care in diabetes – 2008. Diabetes Care 31, Suppl. 1, S12–S54.
52Chobanian AV, Bakris GL, Black HR, et al. (2003) Seventh report of the Joint National Committee on Prevention. Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42, 1206–1252.